Toxicology and Pharmacokinetics of DT₃₈₈IL3, a Fusion Toxin Consisting of a Truncated Diphtheria Toxin (DT₃₈₈) Linked to Human Interleukin 3 (IL3), in Cynomolgus Monkeys

This publication has 25 references indexed in Scilit:

• Diphtheria toxin-interleukin-3 fusion protein (DT388IL3) prolongs disease-free survival of leukemic immunocompromised mice
  Leukemia, 2003
• Acute myeloid leukemia in adults: where do we go from here?
  Cancer Chemotherapy and Pharmacology, 2001
• Evaluating the contribution of allogeneic and autologous transplantation to the management of acute myeloid leukemia in adults
  Cancer Chemotherapy and Pharmacology, 2001
• Molecular Characterization of Key Diphtheria Toxin:Receptor Interactions
  Biochemical and Biophysical Research Communications, 2000
• Toxicology and Pharmacokinetics of DTGM, a Fusion Toxin Consisting of a Truncated Diphtheria Toxin (DT388) Linked to Human Granulocyte-Macrophage Colony-Stimulating Factor, in Cynomolgus Monkeys
  Toxicology and Applied Pharmacology, 1999
• High-Level Expression and Purification of the Recombinant Diphtheria Fusion Toxin DTGM for PHASE I Clinical Trials
  Protein Expression and Purification, 1999
• The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration.
  Proceedings of the National Academy of Sciences, 1993
• The crystal structure of diphtheria toxin
  Nature, 1992
• Permissive role of interleukin 3 (IL‐3) in proliferation and differentiation of multipotential hemopoietic progenitors in culture
  Journal of Cellular Physiology, 1985
• [38] Diphthamide in elongation factor 2: ADP-ribosylation, purification, and properties
  Published by Elsevier ,1984